Drug Research
Development of First-In-Class Antibody Therapeutics and New Acquisition Brings Hope to Patients with Fibrotic and Inflammatory Diseases
The breakthrough discovery of investigational therapies for multiple human diseases by a team of Singapore clinicians, clinician scientists and scientists from National Heart Centre Singapore (NHCS), SingHealth Duke-NUS AMC and the Singapore based biotech company Enleofen Bio, along with...
Drug Research
Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics
Velabs Therapeutics GmbH, a biotech company focused on the rapid screening of functional therapeutic antibodies announced that it has entered into an exclusive licence agreement with alytas therapeutics GmbH , for the development and commercialization of alytas’ antibodies in...
Drug Research
BeiGene obtains certain rights for Leap Therapeutics cancer drug
Chinese biopharmaceutical firm BeiGene has agreed to exclusive rights to develop and commercialise Leap Therapeutics’ cancer drug DKN-01 in the Asia Pacific region, excluding Japan.
Under the agreement, Leap will continue to have sole rights to develop, manufacture and commercialise...
Drug Research
Arena Pharmaceuticals and Beacon Discovery Expand Strategic Relationship Focusing on Multiple Immune and Inflammatory Targets
Arena Pharmaceuticals, Inc. and Beacon Discovery announced that they entered into a strategic multi-year partnership (Project Cabrillo) aimed at building novel medicines across a range of G protein-coupled receptor (GPCR) targets.
Under the terms of the deal, Beacon will be...
Drug Research
Vaccitech partners with CRUK on NSCLC immunotherapeutic vaccine
Vaccitech has signed a partnership with Cancer Research UK (CRUK) to clinically advance VTP-600, the former’s immunotherapy vaccine candidate, for patients with non-small cell lung cancer (NSCLC).
According to the terms of the agreement, CRUK’s Centre for Drug Development will...
Drug Research
Aptar Pharma to Highlight Drug Delivery Solutions Portfolio and Expanded Services Offering at Pharmapack 2020
Aptar Pharma, a global leader in drug delivery systems and active packaging solutions, announces that it will be a leading exhibitor at Pharmapack 2020, which will take place February 5-6 at Paris Expo, Porte de Versailles, in Paris, France.
Located...
Drug Research
Novartis and Forendo enter into tissue hormone focused licensing collaboration
Finland-based Forendo Pharma has announced it has signed a licensing and collaboration agreement with Novartis.
The research collaboration will focus on discovering and developing HSD17B (17-beta-hydroxysteroid dehydregonase) inhibitors, which is a family of enzymes that regulates hormone action in specific...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read